focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInsig Ai Plc Regulatory News (INSG)

Share Price Information for Insig Ai Plc (INSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.75
Bid: 12.00
Ask: 13.50
Change: -0.50 (-3.77%)
Spread: 1.50 (12.50%)
Open: 13.25
High: 13.25
Low: 12.75
Prev. Close: 13.25
INSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partnership agreement with BRAIN

17 Oct 2022 07:00

RNS Number : 0056D
Insig AI Plc
17 October 2022
 

REACH

17 October 2022

 

Insig AI plc

("Insig AI" or the "Company")

 

Partnership agreement with BRAIN

Insig AI plc (AIM: INSG), the data science and machine learning group, is pleased to announce that it has signed a data partnership agreement with BRAIN, a research company specialising in Natural Language Processing ("NLP") applications and algorithms for investment strategies.

BRAIN has a team of data science and financial markets experts that work to deliver unique derived datasets and machine learning models to its end customers. With access to Insig FilingDB-Europe, the team at BRAIN now has access to valuable corporate filings and structured JSON text. This will allow them to build a unique derived group of data points to bring investable actions to their hedge fund clients, focused on the European equities market.

 

Colm McVeigh, Chief Executive Officer of Insig AI commented:

"We are excited to provide our unique European corporate filings dataset to BRAIN which are experts in the field of building algorithmic investment strategies. This partnership came about because BRAIN was in search of corporate filings content similar to how the SEC EDGAR data is delivered. At Insig AI our team collects these valuable documents at the point of publication, transforms the content into machine readable text and then tags the relevant content against business-oriented classifiers such as CEO/CFO speaking, revenue guidance and business risks.

"This high-quality output enables firms like BRAIN to conduct in-depth research on over one thousand European firms to test their investment hypotheses and build out trading signals for systematic hedge funds to make decisions with."

 

Francesco Cricchio, Chief Executive Officer of BRAIN commented:

"We are convinced that the combination of the advanced Insig FilingDB dataset with BRAINs powerful NLP platform will produce an insightful structured dataset from highly unstructured sources such as European company filings that can be a relevant input to systematic strategies."

 

For further information, please visit www.insg.ai or contact: 

Insig AI plc

Colm McVeigh (CEO)

 

Via SEC Newgate

Zeus (Nominated Adviser & Broker)

David Foreman / James Hornigold / Danny Philips

 

 

+44 (0)20 3829 5000

 

SEC Newgate (Financial Communications)

Robin Tozer / Richard Bicknell / Max Richardson

 

 

+44 (0) 7540 106 366

insigai@secnewgate.co.uk

 

 

About BRAIN

BRAIN is a Research Company based in Milan, Italy that creates proprietary datasets and algorithms for investment strategies, combining experience on financial markets with strong competences in Statistics, Machine Learning and Natural Language Processing.

BRAIN also supports Clients in developing, optimizing and validating their own proprietary models.

 

https://braincompany.co/

 

About Insig AI

Insig AI is a data science and machine learning solutions company with a particular focus on

the asset management industry. The Company's products are designed to adapt to and

enhance investment strategies; enabling asset managers to transition to a data-centric

business model, advance and scale their analytical potential and gain value, speed, and

strategic leverage.

 

https://www.insg.ai/

 

This is a Reach announcement and the information contained is not considered to be material or to have a significant impact on management's expectations of the Company's performance. Reach is an investor communication service aimed at assisting listed companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFLRIILSLIF
12
Date   Source Headline
9th Sep 20227:00 amRNSFinal Results, Posting of Report and Notice of GM
8th Sep 20227:00 amRNSNotice of AGM
30th Aug 20227:00 amRNSConvertible Loan Facility Agreement and Drawdown
2nd Aug 20227:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSDirector/PDMR Shareholding
26th Jul 20227:00 amRNSConvertible Loan Facility Agreement drawdown
19th Jul 20227:00 amRNSDirectors' Disclosure
6th Jul 20227:00 amRNSDirector/PDMR Shareholding
1st Jul 20227:00 amRNSDirector/PDMR Shareholding
17th Jun 202210:30 amRNSConvertible loan agreement and drawdown
31st May 20227:00 amRNSData partnership and research agreement
5th May 20227:00 amRNSData share partnership agreement with Snowflake
4th May 20227:00 amRNSConvertible Loan Facility Agreement and drawdown
28th Apr 20227:00 amRNSUpdate on agreement with CarVal Investors, L.P
26th Apr 20227:00 amRNSDirector/PDMR Shareholding
25th Apr 20227:00 amRNSContract win, trading update and Board changes
11th Apr 20227:00 amRNSDirectorate Change
24th Mar 20227:00 amRNSDirector/PDMR Shareholding
22nd Mar 20227:00 amRNSDirector/PDMR Shareholding
21st Mar 20227:00 amRNSTrading and operations update
25th Feb 20227:00 amRNSFurther agreement with CarVal Investors, L.P.
7th Feb 20227:00 amRNSInsig AI selected for PwC Scale FinTech programme
14th Jan 20227:00 amRNSDirector/PDMR Shareholding
6th Jan 20221:41 pmRNSDirector/PDMR Shareholding
30th Dec 20217:00 amRNSDirectorate change
23rd Dec 202112:55 pmRNSDirector/PDMR Shareholding
23rd Dec 20218:42 amRNSDirector/PDMR Shareholding
22nd Dec 20217:00 amRNSInterim Results
13th Dec 20217:00 amRNSContract win
10th Dec 20217:00 amRNSColm McVeigh appointment to the Board
19th Nov 202111:36 amRNSDirector/PDMR Shareholding
19th Nov 20217:00 amRNSDirector/PDMR Shareholding
18th Nov 20217:00 amRNSAcquisition of FDB Systems Limited
15th Nov 20217:00 amRNSProof of concept signed with asset manager
10th Nov 20217:00 amRNSESG scoring solution delivered to CarVal Investors
10th Nov 20217:00 amRNSColm McVeigh appointed as Chief Commercial Officer
4th Nov 20217:00 amRNSInvestor Presentation
1st Nov 20217:00 amRNSInsig AI Becomes a Sponsor of the UK's APPG on ESG
4th Oct 20217:00 amRNSRelease of Insig Portfolio 2.0
30th Sep 202111:10 amRNSResult of AGM
15th Sep 20217:00 amRNSLaunch of Insig ESG
17th Aug 20217:00 amRNSCarVal HY and IG product lines partnership
13th Aug 20217:30 amRNSDirectorate changes
23rd Jul 20217:00 amRNSInsig to support CarVal Clean CLO Product Line
20th Jul 20218:04 amRNSLicense win and ESG product developments
20th Jul 20217:00 amRNSLicense win and ESG product developments
18th May 20213:43 pmRNSHolding(s) in Company
10th May 20216:04 pmRNSHolding(s) in Company
10th May 20215:59 pmRNSHolding(s) in Company
10th May 20217:00 amRNSAdmission to Aim and First Day of Dealings
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.